The Patent Finder
AL

Acp Lantern Acquisition, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 6 US patents in force on its record. from the record

Of the 6 now held by other companies, 5 passed to Lantheus Medical Imaging Inc. when this company merged into it, and 1 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2010 to 2029.
US 8,263,042 Contrast Agents for Myocardial Perfusion Imaging Feb 21, 2027
US 10,010,631 Ligands for Imaging Cardiac Innervation no later than Dec 21, 2027
US 11,241,509 Ligands for Imaging Cardiac Innervation Dec 21, 2027
US 8,226,929 Contrast Agents for Myocardial Perfusion Imaging Jun 21, 2028
US 12,324,845 Ligands for Imaging Cardiac Innervation no later than Dec 28, 2028
US 7,824,659 Methods of Making Radiolabeled Tracers and Precursors Thereof Sep 1, 2029
20142018202220262029
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
Every computed term in this portfolio is shown above.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 41 later US patents, top 25% of utility patents granted in 2012 in our data. Protection runs to 2028.
merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc.
Ends Jun 2028 · High confidence
Also notable
Cited by 34 later US patents, top 25% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc.
Ends Feb 2027 · High confidence
Also notable
The largest patent family in this portfolio, 5 related applications, renewed at every maintenance window due so far. Protection runs to 2027. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
merged into Bristol Myers Squibb Medical Imaging Inc. - now held by Lantheus Medical Imaging, Inc.
Ends no later than Dec 2027 · Medium confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first.
Also on record: 6 patents in force now held by others · 42 patents ended · 16 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
17 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
18 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited